John W Ostrominski

31PUBLICATIONS

101CO-AUTHORS

Medical devicesRespiratory diseasesGeneral practiceCardiology (incl. cardiovascular diseases)Pharmaceutical delivery technologies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (31)

Sort by Publication Date:

|Oct 10, 2026

Body Mass Index, Valsartan, and Myocardial Remodeling in Early-Stage Hypertrophic Cardiomyopathy: A Secondary Analysis of the Randomized VANISH Trial.

|Aug 17, 2026

Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction.

|Aug 16, 2026

A Remote Program for Navigator- and Pharmacist-Led Management of Obesity Medications in Adults: Rationale, Design, and Implementation.

|Apr 01, 2026

Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study.

Mats C Højbjerg Lassen, John W Ostrominski, Brian L Claggett

|Mar 04, 2026

Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations.

John W Ostrominski, Janinne Ortega-Montiel, Deborah J Wexler

|Sep 08, 2025

Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS-HF trial.

John W Ostrominski, Brian L Claggett, Akshay S Desai

Pageof 6

Frequent Collaborators

20 joint publications

Muthiah Vaduganathan

Scott D Solomon

Pardeep S Jhund

John J V McMurray

Sanjiv J Shah

Akshay S Desai

Brian L Claggett

Faiez Zannad

Zi Michael Miao

Brian L Claggett

Frequent Collaborators

20 joint publications

Muthiah Vaduganathan

8 joint publications

Scott D Solomon

6 joint publications

Pardeep S Jhund

5 joint publications

John J V McMurray